EUVIMEDEUVIMED entdecken
Open Access

IL1B-Expressing Exhausted CD4 + T Cells Are Associated With Disease Aggressiveness in Glioblastoma

Jinshan Wang, A O Zhu, Jian Wang, Bin Hu, Kashif Rafiq Zahid, Ailiang Zeng, Yiheng Tan, Jia Yang

Cancer Genomics - Proteomics · 2026-07 · 23 (4) · 730-754

DOI: 10.21873/cgp.20599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, online erschienen am 29.06.2026. Verfasst von Jinshan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, CD4-Positive T-Lymphocytes, Interleukin-1beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Glioblastomas (GBMs) are aggressive primary brain tumors characterized by immune evasion and therapeutic resistance. Here, we aimed to decipher the transcriptional landscape of disease aggressiveness in GBM by employing a multi-layered transcriptomic approach. MATERIALS AND METHODS: We performed transcriptome-wide differential expression analysis using TCGA IDH-wildtype GBM data after stratifying the tumors based on epithelial-mesenchymal transition (EMT) signature scores. Functional and pathway enrichment analyses, STRING-based protein-protein interaction (PPI) network assisted with centrality and random-walk analyses, univariate and multivariate Cox survival analyses, Gene Set Enrichment Analysis (GSEA), single-cell RNA (scRNA) sequencing analysis, CIBERSORTx immune deconvolution, and T cell exhaustion profiling were performed. Key findings were validated in independent datasets. RESULTS: We identified 2088 protein-coding genes associated with disease aggressiveness in GBM. Among 1070 upregulated genes, 432 were risk-associated and enriched for immune-inflammatory pathways. Network analysis identified IL1B and CD4 as top hub genes, both of which were independently prognostic for poor overall survival. scRNA-seq analysis attributed CD4 expression to tumor-infiltrating T cells, more than half of which also co-expressed IL1B. CIBERSORTx deconvolution suggested progressive accumulation and exhaustion of CD4+ T memory resting cells and Tregs along disease aggressiveness. CCL5 is preferentially expressed by tumor cells, whereas CCR1 and CCR5 by CD4+ T cells, supporting a CCL5-CCR1/CCR5-associated recruitment pattern. IL1B correlates with accumulation of exhausted CD4+ T memory cells and aligns with enrichment of disease aggressiveness and inflammatory signatures. IL1R1/NF-κB-related transcriptional targets downstream are coordinately upregulated in tumors having high EMT scores and high IL1B expression. CONCLUSION: CD4+ T cells are recruited to GBM tumors preferentially via the CCL5-CCR1/CCR5 axis, where their exhaustion-related IL1B upregulation along disease progression aligns with mesenchymal reprogramming that hallmarks disease aggressiveness in IDH-wildtype GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsCD4-Positive T-LymphocytesInterleukin-1betaHumansT-Cell ExhaustionGene Expression Regulation, NeoplasticPrognosisEpithelial-Mesenchymal TransitionGene Expression Profiling

Stichwörter der Autor:innen

CD4GlioblastomaIL1BT cell exhaustionepithelial-mesenchymal transitiontumor microenvironment

Substanzen

Interleukin-1betaIL1B protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China.
  • Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China.
  • Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, U.S.A.
  • Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A.; ailiang.zeng@mountsinai.org y.tan@umcg.nl yangj583@alumni.sysu.edu.cn.
  • Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; ailiang.zeng@mountsinai.org y.tan@umcg.nl yangj583@alumni.sysu.edu.cn.
  • Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China; ailiang.zeng@mountsinai.org y.tan@umcg.nl yangj583@alumni.sysu.edu.cn.

Zitieren

APA

Wang, J., Zhu, A. O., Wang, J., Hu, B., Zahid, K. R., Zeng, A., Tan, Y., & Yang, J. (2026). IL1B-Expressing Exhausted CD4 + T Cells Are Associated With Disease Aggressiveness in Glioblastoma. Cancer Genomics - Proteomics, 23(4), 730-754. https://doi.org/10.21873/cgp.20599

Vancouver

Wang J, Zhu AO, Wang J, Hu B, Zahid KR, Zeng A, et al. IL1B-Expressing Exhausted CD4 + T Cells Are Associated With Disease Aggressiveness in Glioblastoma. Cancer Genomics - Proteomics. 2026;23(4):730-754. doi:10.21873/cgp.20599

BibTeX
@article{Wang2026,
  author = {Wang, Jinshan and Zhu, A O and Wang, Jian and Hu, Bin and Zahid, Kashif Rafiq and Zeng, Ailiang and Tan, Yiheng and Yang, Jia},
  title = {IL1B-Expressing Exhausted CD4 + T Cells Are Associated With Disease Aggressiveness in Glioblastoma},
  journal = {Cancer Genomics - Proteomics},
  year = {2026},
  volume = {23},
  number = {4},
  pages = {730--754},
  doi = {10.21873/cgp.20599}
}
Kostenlos starten →